1-20 of 2,226 results for dept:"Ministry of Defence"
Librarians' tools
- Search time
- 0.339 seconds
- Solr query time
- 0.036 seconds
- Search query
- dept:"Ministry of Defence"
- We searched for
- department_t:"Ministry of Defence" OR department_t:MOD OR department_ses:45998 OR answeringDept_ses:45998
Type
House
Session
Year
Department
More
Member
More
Primary member
Answering member
More
Legislative stage
Legislation
More
Subject
More
Publisher
To ask the Secretary of State for Defence, if he will ensure that the MOD Defence Medical Service updates its policy on Mefloquine-damaged veterans to (a) acknowledge the recent confirmation by NHS England that Mefloquine neurotoxicity (i) exists and (ii) requires clinical management, (b) accept that misdiagnosis of Mefloquine-damaged veterans...
To ask the Secretary of State for Defence, if he will ensure that the MOD Defence Medical Service updates its policy on Mefloquine-damaged veterans to (a) acknowledge the recent confirmation by NHS England that Mefloquine neurotoxicity (i) exists and (ii) requires clinical management, (b) accept that misdiagnosis of Mefloquine-damaged veterans...
I refer the hon. member to the answer provided by the Department of Health and Social Care (DHSC) in January this year. https://questions-statements.parliament.uk/written-questions/detail/2026-01-12/104605
The Ministry of Defence (MOD) and DHSC recognise that mefloquine is associated with neurological and psychiatric adverse effects. Defence Medical Command (DMedC) support an approach to healthcare in which treatment is directed towards the patient’s clinical diagnosis and presenting symptoms and managed in accordance with current evidence-based clinical practice and relevant national guidance. DMedC is not aware of evidence or national guidance that recommends withholding otherwise appropriate treatments where clinically indicated, solely on the basis of previous mefloquine exposure.
The MOD will continue to review emerging evidence, including systematic reviews, regulatory advice from the Medicines and Healthcare products Regulatory Agency (MRHA) and recommendations from expert bodies concerned with malaria prevention.
As outlined in the response by the former Minister for Health Innovation and Safety, NHS England is considering adding screening for prior mefloquine use and any associated adverse events to initial Op COURAGE and Op RESTORE assessments.
To ask the Secretary of State for Defence, if he will make it his policy to include within the Financial Recognition Scheme ("FRS") those veterans who resigned from the armed forces as a result of pressure to do so on account of their sexual orientation; if he will ensure that...
To ask the Secretary of State for Defence, if he will make it his policy to include within the Financial Recognition Scheme ("FRS") those veterans who resigned from the armed forces as a result of pressure to do so on account of their sexual orientation; if he will ensure that...
The scope of the Financial Recognition Scheme (FRS) already includes those who felt pressured to resign and they are encouraged to apply for the LGBT Impact Payment. The Impact Payment is assessed by an Independent Panel, separate from and independent of Defence, and provides recognition for a broad range of impacts felt under the Ban, including experiencing pressure to resign.
Defence does not require applicants to provide service records to support their application and encourages veterans to apply with their own personal testimonies. Subject Access Requests from any individuals, not just LGBT veterans, can take time to complete, not only due to high demand but also as records are stored in multiple locations. Prioritising requests from LGBT veterans would be unfair on other veterans applying to other Defence schemes that do require such evidence.
All applications are considered on a basis of reverse burden of proof; the information provided by the applicant will be accepted if the reported events are more likely to have occurred than not, unless there is evidence on their case file to the contrary. This approach prevents applicants being disadvantaged due to records being incomplete through no fault of their own.
To ask the Secretary of State for Defence, whether he has met with Fighting with Pride to discuss the operation of the Financial Recognition Scheme.
To ask the Secretary of State for Defence, whether he has met with Fighting with Pride to discuss the operation of the Financial Recognition Scheme.
The Ministry of Defence values the insights and expertise of partners from across the charity sector and welcomes regular dialogue. Defence Ministers and officials regularly meet with its representatives, including the Chief Executive Officer.
To ask the Secretary of State for Defence, what assessment he has made of whether the Independent Impact Panel has sufficient capacity to determine all outstanding claims, before the Financial Recognition Scheme closes, made by veterans pressured into leaving the armed forces on account of their sexuality.
To ask the Secretary of State for Defence, what assessment he has made of whether the Independent Impact Panel has sufficient capacity to determine all outstanding claims, before the Financial Recognition Scheme closes, made by veterans pressured into leaving the armed forces on account of their sexuality.
Defence is committed to ensuring all applications are completed equitably and in the timeliest manner possible. Steps have been taken to increase the speed of processing Impact Payment applications, including recruiting both an additional Independent Panel Chair and Members, thereby enabling further Panel sittings each week. Application numbers and processing speeds are continually monitored to ensure any additional measures are taken to enable the conclusion of all applications by, or soon after, the time the Scheme closes for applications.
Having spoken on this very subject the week before last, I thought that I would, for once, sit and listen to what others have to say. Does my right hon. Friend agree that one of the reasons for the failure of deterrence at the beginning of both the second world...
Having spoken on this very subject the week before last, I thought that I would, for once, sit and listen to what others have to say. Does my right hon. Friend agree that one of the reasons for the failure of deterrence at the beginning of both the second world...
Will the Minister give way?
Will the Minister give way?
I congratulate the Minister on acceding to office, but he needs to appreciate that the cost of all Departments goes up in absolute financial numerical terms year on year, but the way in which we measure the investment in defence is by looking at it as a proportion of GDP....
I congratulate the Minister on acceding to office, but he needs to appreciate that the cost of all Departments goes up in absolute financial numerical terms year on year, but the way in which we measure the investment in defence is by looking at it as a proportion of GDP....
My salary is “up to” £1 billion a year, but sadly that does not make me a billionaire. [Laughter.] Does the Secretary of State accept that when checking how much money a country is spending on defence, the accepted way of doing it is by percentage of GDP?
My salary is “up to” £1 billion a year, but sadly that does not make me a billionaire. [Laughter.] Does the Secretary of State accept that when checking how much money a country is spending on defence, the accepted way of doing it is by percentage of GDP?
If the right hon. Gentleman is talking about a salary of up to £1 billion, he is cosplaying as the hon. Member for Clacton (Nigel Farage), isn’t he? Seriously, we are the third-largest cash spender in NATO. At the spending review next year, we will be setting out an increase in defence spending. That is what every Defence Minister wants to see and, I imagine, what those on all sides of the House want to see. It is not just what we spend on defence that is important; it is how we spend it and on what capabilities. As can be seen from the DIP, we are transforming our armed forces to be more capable, more lethal and better able to defend the UK and our allies.
At last, we have agreement on a defence expenditure statistic. When the Secretary of State says that what the settlement means is that the proportion of GDP spent on defence by the end of this decade will now be higher than at any time in the past 30 years, he...
At last, we have agreement on a defence expenditure statistic. When the Secretary of State says that what the settlement means is that the proportion of GDP spent on defence by the end of this decade will now be higher than at any time in the past 30 years, he...
One of the strong arguments put forward for the legislation is that it will help families to find out the truth of what happened to their loved ones, yet by repealing the Conservative legislation, it makes that less likely rather than more likely—because who is going to come forward and...
One of the strong arguments put forward for the legislation is that it will help families to find out the truth of what happened to their loved ones, yet by repealing the Conservative legislation, it makes that less likely rather than more likely—because who is going to come forward and...
Another spurious argument, which I am afraid we heard earlier in the debate, is that the legislation put our armed forces on the same level as terrorists. The truth is that everybody is on the same level before the law. In any case, the Northern Ireland (Sentences) Act 1998 sold...
Another spurious argument, which I am afraid we heard earlier in the debate, is that the legislation put our armed forces on the same level as terrorists. The truth is that everybody is on the same level before the law. In any case, the Northern Ireland (Sentences) Act 1998 sold...
This debate has been characterised by so many powerful speeches that I think it would be invidious to pick out any of them. I congratulate everyone who has contributed, particularly the Government Back Benchers who have evidently come to the debate espousing the principle that the best defence is attack....
This debate has been characterised by so many powerful speeches that I think it would be invidious to pick out any of them. I congratulate everyone who has contributed, particularly the Government Back Benchers who have evidently come to the debate espousing the principle that the best defence is attack....
I know the Minister accepts that I have criticised successive Governments for not spending anything like the 4.5% that Margaret Thatcher used to spend on defence at the height of the cold war throughout the 1980s, but does he accept that the service chiefs have made an objective assessment of...
I know the Minister accepts that I have criticised successive Governments for not spending anything like the 4.5% that Margaret Thatcher used to spend on defence at the height of the cold war throughout the 1980s, but does he accept that the service chiefs have made an objective assessment of...
May I wish the new Secretary of State the best of luck in his new post and express the hope that the appearance of the Chancellor of the Exchequer alongside him on his first outing is not too symbolic of what has perhaps been going on in backrooms behind the...
May I wish the new Secretary of State the best of luck in his new post and express the hope that the appearance of the Chancellor of the Exchequer alongside him on his first outing is not too symbolic of what has perhaps been going on in backrooms behind the...
May I offer some advice to Defence Ministers in their bare-knuckle fight with the Treasury for adequate defence funding? They really should move away from this glib spin doctor’s line about defence expenditure rising faster now than at any time since the end of the cold war. The situation we...
May I offer some advice to Defence Ministers in their bare-knuckle fight with the Treasury for adequate defence funding? They really should move away from this glib spin doctor’s line about defence expenditure rising faster now than at any time since the end of the cold war. The situation we...
To ask the Secretary of State for Defence, with reference to the Fourth Report of the Defence Committee of Session 2014-15 entitled An acceptable risk? The use of Lariam for military personnel, HC 567, published on 10 May 2016, how many Service personnel were issued with (a) Lariam (Mefloquine) and...
To ask the Secretary of State for Defence, with reference to the Fourth Report of the Defence Committee of Session 2014-15 entitled An acceptable risk? The use of Lariam for military personnel, HC 567, published on 10 May 2016, how many Service personnel were issued with (a) Lariam (Mefloquine) and...
The Department continues to monitor and publish bi-annual statistics on the number of prescriptions for mefloquine (also known as Larium) given to UK armed forces personnel at Ministry of Defence medical facilities since 12 September 2016. The full release of information can be found at the following link:
The number of all antimalarials prescribed to armed forces personnel during the period Sept 2016 to 30 March 2023 is available at Table 1 at the following link:
There were 29,830 antimalarials, not including mefloquine, prescribed between 1 April 2023 – 30 September 2025. Table 1, below, provides this information by 6-month period and year. Antimalarials include prescriptions for doxycycline. Doxycycline may have been prescribed for antibiotic or antimalarial purposes.
Table 1: Other antimalarial prescriptions1 by annual and six-month period, numbers
1 April 2023 to 30 September 2025
Financial Year | Other Antimalarial Annual Total | Six month period | Other Antimalarial Six Monthly Total |
2023/24 | 13,749 | 01-Apr-23 to 30-Sep-23 | 8,423 |
|
| 01-Oct-23 to 31-Mar-24 | 5,326 |
2024/25 | 10,414 | 01-Apr-24 to 30-Sep-24 | 5,511 |
|
| 01-Oct-24 to 31-Mar-25 | 4,903 |
2025/262 | 5,667 | 01-Apr-25 to 30-Sep-25 | 5,667 |
1 Does not include mefloquine prescriptions.
2 Includes prescriptions between 1 April 2025 and 30 September 2025 only.
To ask the Secretary of State for Defence, what steps have (a) the Surgeon General’s Office and (b) the Ministry of Defence more widely taken as a result of the 2016 recommendations of the Defence Committee report (HC567) on its inquiry into the harmful effects of Lariam (Mefloquine) on some...
To ask the Secretary of State for Defence, what steps have (a) the Surgeon General’s Office and (b) the Ministry of Defence more widely taken as a result of the 2016 recommendations of the Defence Committee report (HC567) on its inquiry into the harmful effects of Lariam (Mefloquine) on some...
The Defence Committee Report (HC567) made a series of recommendations on the Ministry of Defence (MOD) use of mefloquine (trade name Lariam), individual risk assessments, research undertaken research on mefloquine, and comparisons with the use of mefloquine by allies.
In response to the report, MOD introduced a new policy on prescribing antimalarial drugs on 12 September 2016. Anti-malaria drugs, including mefloquine, are only prescribed after a face-to-face individual risk assessment. The recommended anti-malaria drug is determined by the sensitivity of malaria parasites to those drugs in different parts of the world based on UKHSA guidance. Mefloquine is only prescribed by a doctor and after all other alternatives have been identified as unsuitable.
In all cases, the authority and supply details for anti-malarial drugs are recorded on the individual’s medical note. Personnel supplied with anti-malarial drugs are issued copies of all manufacturer-provided patient documentation relevant to that drug and are informed of all special warnings or precautions relevant to anti-malarial drugs.
The Department continues to monitor and publish bi-annual statistics on the number of mefloquine prescriptions given to UK Armed Forces personnel at MOD medical facilities.
The latest release of information can be found at the following link:
The next release is due to be published on 28 May 2026 and will include data from 12 September 2016 to 31 March 2026.
The MOD continues to monitor the use of mefloquine and other anti-malarial drugs by allies. This includes the extent to and circumstances in which mefloquine is prescribed.
The Department previously outlined its intention to conduct a research proposal into the impact of adverse effects of anti-malaria drugs focusing on the performance of military personnel exercising in Kenya. The study, ‘Impact of anti-malarial chemoprophylaxis on functional effectiveness of military personnel’ (713/MODREC/15) was initiated and data on the impact of anti-malarial chemoprophylaxis on the functional effectiveness of military personnel collected from two British Army Training Unit Kenya (BATUK) battlegroups between 2017-18. Following a delay in the analysis of the data, the department intend to undertake further work to be able publish the findings in a peer reviewed journal in 2027.
To ask the Secretary of State for Defence, what guidance his Department has provided to the NHS on appropriate treatment for former Service personnel presenting with suicidal ideation resulting from brain injury caused by neurological side-effects of Lariam (Mefloquine) antimalarial prophylaxis; and how such guidance differs from that required for...
To ask the Secretary of State for Defence, what guidance his Department has provided to the NHS on appropriate treatment for former Service personnel presenting with suicidal ideation resulting from brain injury caused by neurological side-effects of Lariam (Mefloquine) antimalarial prophylaxis; and how such guidance differs from that required for...
Mefloquine, trade name Lariam, is recommended as an effective anti-malarial by international health agencies, including the World Health Organisation. Ministry of Defence (MOD) and the National Health Service both follow National Institute for Care and Excellence guidelines on the prescription and management of side effects associated with mefloquine.
MOD is engaged with NHS England (NHSE) through the NHSE Armed Forces Clinical Reference Group. This group has reviewed the clinical management of the side effects associated with mefloquine. As symptoms can resemble acute psychiatric conditions, clinicians are advised to assess patients individually and are expected to take a full drug and alcohol history, including any previous mefloquine use.
The side effects that may be experienced whilst taking, or with a history of having taken mefloquine, will be treated according to the diagnosis; for example, if the patient is experiencing depressive symptoms, the treatment for depression will be instigated.
Since 2016, MOD has admitted mefloquine can cause minor psychiatric injury in certain individuals for a limited period of time. Causation of long-term psychiatric injury is denied.
I would encourage any Veteran who is struggling with their mental health to self-refer or seek the support of their GP to access Op COURAGE, the Veterans' Mental Health and Wellbeing Service.
To ask the Secretary of State for Defence, when he plans to publish the results of his Department's research study number 713/MoDREC/15 on anti-malarial chemoprophylaxis, including Lariam (Mefloquine).
To ask the Secretary of State for Defence, when he plans to publish the results of his Department's research study number 713/MoDREC/15 on anti-malarial chemoprophylaxis, including Lariam (Mefloquine).
The Defence Committee Report (HC567) made a series of recommendations on the Ministry of Defence (MOD) use of mefloquine (trade name Lariam), individual risk assessments, research undertaken research on mefloquine, and comparisons with the use of mefloquine by allies.
In response to the report, MOD introduced a new policy on prescribing antimalarial drugs on 12 September 2016. Anti-malaria drugs, including mefloquine, are only prescribed after a face-to-face individual risk assessment. The recommended anti-malaria drug is determined by the sensitivity of malaria parasites to those drugs in different parts of the world based on UKHSA guidance. Mefloquine is only prescribed by a doctor and after all other alternatives have been identified as unsuitable.
In all cases, the authority and supply details for anti-malarial drugs are recorded on the individual’s medical note. Personnel supplied with anti-malarial drugs are issued copies of all manufacturer-provided patient documentation relevant to that drug and are informed of all special warnings or precautions relevant to anti-malarial drugs.
The Department continues to monitor and publish bi-annual statistics on the number of mefloquine prescriptions given to UK Armed Forces personnel at MOD medical facilities.
The latest release of information can be found at the following link:
The next release is due to be published on 28 May 2026 and will include data from 12 September 2016 to 31 March 2026.
The MOD continues to monitor the use of mefloquine and other anti-malarial drugs by allies. This includes the extent to and circumstances in which mefloquine is prescribed.
The Department previously outlined its intention to conduct a research proposal into the impact of adverse effects of anti-malaria drugs focusing on the performance of military personnel exercising in Kenya. The study, ‘Impact of anti-malarial chemoprophylaxis on functional effectiveness of military personnel’ (713/MODREC/15) was initiated and data on the impact of anti-malarial chemoprophylaxis on the functional effectiveness of military personnel collected from two British Army Training Unit Kenya (BATUK) battlegroups between 2017-18. Following a delay in the analysis of the data, the department intend to undertake further work to be able publish the findings in a peer reviewed journal in 2027.
I fear I know the answer to this question in advance, but I shall ask it anyway. Would one way of reconnecting society with the armed forces at Armed Forces Day not be to revisit the testimony given to the then Defence Committee in March 2017 by four eminent professors of law? It showed how it is possible to protect veterans from being hauled before the courts for using lethal force against terrorists in the act of committing terrorism. That testimony deserves revisiting. Will the Government re-examine it and reinstate the immunity and the investigative processes that enable that protection to be done?
I fear I know the answer to this question in advance, but I shall ask it anyway. Would one way of reconnecting society with the armed forces at Armed Forces Day not be to revisit the testimony given to the then Defence Committee in March 2017 by four eminent professors of law? It showed how it is possible to protect veterans from being hauled before the courts for using lethal force against terrorists in the act of committing terrorism. That testimony deserves revisiting. Will the Government re-examine it and reinstate the immunity and the investigative processes that enable that protection to be done?
The right hon. Gentleman is well aware of how strongly I believe it is important that those who have been victims have a right to have investigations, including into the murders of British service personnel. I take his point, and I am sure that people are well aware of the point that he makes.